PET scan study for long COVID symptoms
Part of Infections, Lungs & breathing clinical trials.
This study uses a special PET scan to look at inflammation in the body of people with long COVID (symptoms lasting 3+ months after infection). The goal is to understand why symptoms persist and find better ways to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a positive COVID-19 test (home antigen test or lab test) at least 3 months ago.
- For the long COVID group: You still have at least 2 unexplained symptoms lasting 2+ months, including fatigue plus a heart/lung or brain symptom.
- For the control group: You fully recovered from COVID-19 within 4 to 12 weeks with no new health issues after that.
- You can travel to San Francisco or Sacramento for study visits.
- You have had no vaccine of any kind in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special imaging (PET/CT) to understand ongoing breathing problems or tiredness after COVID-19. It aims to learn how inflammation and changes in the body connect to symptoms that last more than 3 months.
This trial studies if brain scans can help understand 'brain fog' in Long COVID. It also looks at how a gentle magnetic stimulation might affect symptoms. If you have ongoing thinking problems after COVID, this study may help find new ways to help.
This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.
This trial uses brain scans to understand why people with long COVID feel very tired or have trouble thinking clearly. It could help find new treatments for these symptoms.
This Phase 2 study uses a special PET scan to look at how active your immune system is after a recent COVID-19 infection. The goal is to understand what the immune response looks like and whether this imaging approach could help guide care.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
Hear when a new PASC Post Acute Sequelae of COVID 19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.